Focus: Procept BioRobotics is a medical device company specializing in Aquablation, a robotic waterjet ablation technology, with a primary focus on benign prostatic hyperplasia (BPH) treatment. The company operates as a focused innovator in the urology/oncology space with 40 active job openings.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Hot — 56 jobs added in 30d
Net +29 (56 new, 27 removed). Aggressive expansion phase.
Best suited for commercial, regulatory, and operations professionals seeking growth-stage medtech exposure; less attractive for researchers or those seeking deep pipeline diversity.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Core commercial product driving 13 distinct clinical trials and the majority of hiring focus.
Help build intelligence for Procept BioRobotics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Procept BioRobotics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo